Southwestern Energy (SWN) Downgraded By Mizuho Securities; Aristeia Capital Has Cut Pacira Pharmaceuticals (PCRX) Holding By $1.77 Million

January 16, 2018 - By Winifred Garcia

Aristeia Capital Llc decreased Pacira Pharmaceuticals Inc (PCRX) stake by 33.52% reported in 2017Q3 SEC filing. Aristeia Capital Llc sold 47,800 shares as Pacira Pharmaceuticals Inc (PCRX)’s stock rose 10.53%. The Aristeia Capital Llc holds 94,800 shares with $3.56M value, down from 142,600 last quarter. Pacira Pharmaceuticals Inc now has $1.68 billion valuation. The stock decreased 1.72% or $0.72 during the last trading session, reaching $41.5. About 1.03M shares traded or 26.65% up from the average. Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) has risen 12.40% since January 16, 2017 and is uptrending. It has underperformed by 4.30% the S&P500.

Among 32 analysts covering Southwestern Energy Company (NYSE:SWN), 9 have Buy rating, 4 Sell and 19 Hold. Therefore 28% are positive. Southwestern Energy Company has $29 highest and $3 lowest target. $10.50’s average target is 91.96% above currents $5.47 stock price. Southwestern Energy Company had 100 analyst reports since July 21, 2015 according to SRatingsIntel. Piper Jaffray maintained Southwestern Energy Company (NYSE:SWN) on Thursday, October 19 with “Hold” rating. The rating was maintained by Barclays Capital with “Overweight” on Monday, October 26. On Wednesday, October 11 the stock rating was maintained by Barclays Capital with “Equal-Weight”. KLR Group upgraded the stock to “Buy” rating in Thursday, November 10 report. UBS downgraded Southwestern Energy Company (NYSE:SWN) rating on Tuesday, April 19. UBS has “Sell” rating and $9 target. The stock has “Buy” rating by Citigroup on Wednesday, March 15. The firm earned “Underweight” rating on Wednesday, October 18 by Morgan Stanley. The rating was maintained by Piper Jaffray with “Hold” on Tuesday, January 9. The rating was reinitiated by GMP Securities on Wednesday, September 28 with “Hold”. The firm earned “Hold” rating on Friday, December 2 by Tudor Pickering.

Analysts await Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) to report earnings on March, 7. They expect $-0.08 earnings per share, up 33.33% or $0.04 from last year’s $-0.12 per share. After $-0.11 actual earnings per share reported by Pacira Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -27.27% EPS growth.

Aristeia Capital Llc increased Spdr Gold Trust (Put) (GLD) stake by 486,500 shares to 566,500 valued at $68.88 million in 2017Q3. It also upped Zions Bancorporation (NASDAQ:ZIONW) stake by 27,100 shares and now owns 2.24M shares. Hostess Brands Inc was raised too.

Investors sentiment decreased to 1.39 in Q3 2017. Its down 0.23, from 1.62 in 2017Q2. It fall, as 35 investors sold PCRX shares while 37 reduced holdings. 29 funds opened positions while 71 raised stakes. 41.63 million shares or 5.80% more from 39.35 million shares in 2017Q2 were reported. Sei Invs Com accumulated 25,539 shares. Pacad Ltd invested 0.02% of its portfolio in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Cortina Asset Management Limited Liability has invested 0.42% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Thompson Davis Com Incorporated, a Virginia-based fund reported 251 shares. Invesco Ltd holds 0.01% or 666,176 shares. Td Cap Limited Liability Corporation holds 0% or 75 shares. The Wisconsin-based State Of Wisconsin Invest Board has invested 0% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Commercial Bank Of Montreal Can, a Ontario – Canada-based fund reported 37,180 shares. Credit Suisse Ag owns 0% invested in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) for 43,563 shares. Point72 Asset Lp accumulated 1.08M shares. Elk Creek Prtnrs Limited owns 612,049 shares for 1.45% of their portfolio. Gilder Gagnon Howe And Ltd Limited Liability Company invested 0.11% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). 5,584 were accumulated by Trexquant Investment Ltd Partnership. Deutsche Bancorp Ag reported 312,847 shares or 0.01% of all its holdings. Alliancebernstein Ltd Partnership owns 0% invested in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) for 58,230 shares.

Since August 15, 2017, it had 0 insider buys, and 5 sales for $2.39 million activity. 28,885 Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) shares with value of $1.16 million were sold by STACK DAVID M. 1,044 shares were sold by HASTINGS PAUL J, worth $37,741 on Tuesday, August 22. 3,461 shares valued at $127,192 were sold by Williams Kristen Marie on Tuesday, August 15. Riker Lauren Bullaro sold 340 shares worth $14,858.

Among 21 analysts covering Pacira Pharmaceuticals (NASDAQ:PCRX), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Pacira Pharmaceuticals had 80 analyst reports since July 28, 2015 according to SRatingsIntel. Nomura initiated Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) on Tuesday, September 29 with “Buy” rating. H.C. Wainwright maintained it with “Buy” rating and $5900 target in Thursday, August 3 report. The company was maintained on Friday, February 26 by Brean Capital. The stock of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) earned “Neutral” rating by Janney Capital on Monday, August 21. The rating was maintained by Piper Jaffray with “Buy” on Wednesday, November 8. The firm has “Buy” rating given on Tuesday, August 29 by Canaccord Genuity. RBC Capital Markets maintained the stock with “Buy” rating in Wednesday, October 11 report. The firm earned “Buy” rating on Wednesday, June 21 by Wedbush. Bank of America maintained Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) rating on Wednesday, October 4. Bank of America has “Buy” rating and $45 target. Wedbush maintained the shares of PCRX in report on Wednesday, May 24 with “Buy” rating.

Southwestern Energy Company, an independent natural gas and oil company, engages in the exploration, development, and production of natural gas and oil in the United States. The company has market cap of $2.76 billion. It operates through two divisions, Exploration and Production, and Midstream Services. It has a 8.79 P/E ratio. The firm focuses on the Marcellus Shale, an unconventional natural gas reservoir covering approximately 245,805 net acres in Northeast Appalachia; Marcellus, Utica, and Upper Devonian Shales covering approximately 321,563 net acres in Southwest Appalachia; and the Fayetteville Shale, an unconventional gas reservoir covering approximately 918,535 net acres in Arkansas.

Analysts await Southwestern Energy Company (NYSE:SWN) to report earnings on February, 22. They expect $0.14 earnings per share, up 75.00% or $0.06 from last year’s $0.08 per share. SWN’s profit will be $70.69 million for 9.77 P/E if the $0.14 EPS becomes a reality. After $0.06 actual earnings per share reported by Southwestern Energy Company for the previous quarter, Wall Street now forecasts 133.33% EPS growth.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>